Qian JJ, Pei H. Detection and clinical significance in patients with hepatitis B immune function [J].Labeled immunoassay analysis and clinical,2008,15(4):198-200.
[2]
Qian JJ, Pei H, Deng L, et al. Detection of hepatitis B immunoglobulin hepatitis protein, complement and clinical significance [J].Chin J Lab Diagn,2009,13(6):836-837.
[3]
Liang XD, Rong Y, Wei TA. Serum immunoglobulin levels in clinical application in the diagnosis and treatment of hepatitis B [J].Clinical Medical Engineering,2012,19(7):1072-1073.
[4]
Saisoong S, Eiam-Ong S, Hanvivatvong O. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3,C4 and clinical activity in lupus patients [J].Clin Exp Rheumatol,2006,24(1): 51-58.
[5]
Qin XM, Tan XM, Qin YJ. Clinical significance of hepatitis B immune globulin test [J].Clinical and Experimental Medicine,2011,10(9):702-703.
[6]
Vasei M, Monabbati A, Alizadeh-Naeeni M, et al. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients [J].Hepatogastroenterology 2008, 55(84):1066-1072.
[7]
Gregorek H, Dzierzanowska-FangratK, Woynarowski M, et al. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-alpha therapy: correlation with specific IgG subclass responses to HBsAg [J].J Hepatol, 2005 42(4):486-490.
